Literature DB >> 12028652

Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis.

Myoung Ja Chung1, Yeon-Lim Suh.   

Abstract

Functional defects and morphological changes of mitochondria have been reported to be in the skeletal muscle of patients with amyotrophic lateral sclerosis (ALS). Recent studies suggested that mitochondrial abnormalities are related to the pathogenesis of ALS. The purpose of this study is to evaluate the ultrastructural changes of muscle mitochondria in ALS patients. The authors examined 49 cases of diagnostic muscle biopsy samples with definite or probable ALS by electron microscopy. Of the 49 cases, 5 (10%) had ultrastructural abnormalities of muscle mitochondria, including giant mitochondria, paracrystalline inclusions, and abnormal cristae. These abnormal mitochondria were mainly observed among subsarcolemmal mitochondrial aggregates.

Entities:  

Mesh:

Year:  2002        PMID: 12028652     DOI: 10.1080/01913120252934260

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  33 in total

Review 1.  Amyotrophic lateral sclerosis and skeletal muscle: an update.

Authors:  O Pansarasa; D Rossi; A Berardinelli; C Cereda
Journal:  Mol Neurobiol       Date:  2013-11-08       Impact factor: 5.590

Review 2.  Mitochondrial medicine for aging and neurodegenerative diseases.

Authors:  P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2008-06-20       Impact factor: 3.843

3.  Deterministic Ratchet for Sub-micrometer (Bio)particle Separation.

Authors:  Daihyun Kim; Jinghui Luo; Edgar A Arriaga; Alexandra Ros
Journal:  Anal Chem       Date:  2018-03-23       Impact factor: 6.986

4.  Methods for imaging mammalian mitochondrial morphology: A prospective on MitoGraph.

Authors:  Megan C Harwig; Matheus P Viana; John M Egner; Jason J Harwig; Michael E Widlansky; Susanne M Rafelski; R Blake Hill
Journal:  Anal Biochem       Date:  2018-03-02       Impact factor: 3.365

Review 5.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 6.  Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?

Authors:  Sandra R Bacman; Walter G Bradley; Carlos T Moraes
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

Review 7.  Mitochondria as a therapeutic target for aging and neurodegenerative diseases.

Authors:  P H Reddy; T P Reddy
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

Review 8.  The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death.

Authors:  H Muyderman; P G Hutson; D Matusica; M-L Rogers; R A Rush
Journal:  Neurochem Res       Date:  2009-04-28       Impact factor: 3.996

Review 9.  Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model.

Authors:  Jingsong Zhou; Ang Li; Xuejun Li; Jianxun Yi
Journal:  Arch Biochem Biophys       Date:  2019-01-22       Impact factor: 4.013

Review 10.  Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?

Authors:  H Muyderman; T Chen
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.